Clinical profile of elderly patients (over 90 years) with type 2 diabetes seen at a diabetes centre in South India.
Background The current life expectancy in India is below 70 years. Type 2 diabetes (T2DM) is known to reduce life expectancy by 6-8 years. Hence elderly people with type 2 diabetes in India would be rare. We report on the clinical profile of Asian Indian patients with T2DM who lived beyond 90 years of age and compared them with 50-60 years T2DM patients. Methods From our Diabetes Electronic Medical Records of over 470,000 diabetes patients, we identified T2DM patients who had lived ≥ 90 years and compared them with 50-60 years age group, matched for gender and duration of diabetes. Clinical data included age at last visit, age at diagnosis, duration of diabetes, family history, smoking and alcohol, details of medications, body mass index (BMI) and blood pressure. Biochemical data included fasting and post prandial plasma glucose, glycated haemoglobin, fasting and stimulated C-peptide levels, lipid profile and renal function studies. Assessment of retinopathy, nephropathy, neuropathy, coronary artery disease and peripheral vascular disease were also done. Results 325 T2DM patients aged ≥ 90 years and 278 type 2 diabetic patients aged between 50-60 years were selected for the study. The T2DM ≥ 90 years, had higher systolic blood pressure (p<0.001) and lower BMI (p<0.001) compared to those between 50-60 years. Prevalence of retinopathy (29.7% vs 53.5%) and macroalbuminuria (3.7% vs 16.0%) were lower in the ≥90 years T2DM, compared to the 50-60 years age group. However, prevalence of neuropathy (89.8% vs 50.8%), peripheral vascular disease (13.5% vs 2.0%) and coronary artery disease (60.3% vs 32.0%) were higher among the ≥90 years T2DM patients. Eighty five percent of the T2DM ≥ 90 years group were on oral hypoglycemic agents (OHA'S), (of whom 64.9% were on sulphonylurea), 12% were on insulin and 3% on diet alone. Among the 50-60 years old, 87.8% were on OHA'S and 12.2% on insulin. Conclusions This is the first report on the clinical profile of Asian Indians with T2DM patients aged 90 years or above and significant differences are seen in their clinical profile compared to younger age T2DM patients.